Flow Home Page

Maximise treatment outcomes.
 Minimise treatment barriers.

Your patients deserve more than standard solutions.

Expand your depression treatment offerings with an innovative, evidence-based solution. Designed for your patients to use comfortably at home. Flow combines transcranial direct current stimulation (tDCS) with digital cognitive behavioral therapy in one app. This method is safe, well-tolerated and can be used alone or in addition to medication and psychotherapy.

Discover the new generation of depression care – book a zoom or phone call, we will gladly help you introduce Flow for optimal results.

Clear evidence supporting your clinical approach

Used in clinics for over 25 years

tDCS has been proven to be safe and effective across multiple trials.

+20 clinical trials

Multiple large, clinical trials into tDCS demonstrate it is safe and effective.

77% report improvement

Reported; In our real-world database of over 14’000 users, patients see improvements within 3 weeks.

Treat depression differently digital, effective, accessible

Flow is designed to optimise outcomes for both patients and clinicians by offering tailored solutions for each.

Patients are equipped with the Flow tDCS headset and companion app, allowing them to conveniently manage their treatment from home. Clinicians benefit from a remote monitoring platform that provides real-time insights into patient adherence, outcomes, and supports data-driven care decisions.

Clinicians can adjust and customise patient stimulation schedules according to clinical need*.

*Subject to clinical qualifications and training.

A Swiss perspective: Dr. med. Jihed Sehli on transforming 
depression treatment

"Flow has transformed the way I treat depression."

In this video, Dr. med. Jihed Sehli explains why he recommends Flow, how it fits into his treatment process, and the positive changes he has observed.

"Integration was straightforward. Many of my patients report real progress and appreciate the independence the treatment allows."
– Dr. med. Jihed Sehli, psychiatrist & psychotherapist, Freiburg, Switzerland

From science to practice — effective in daily use

New pathways to remission

Flow fits easily into exisiting care plans to help provide new pathways to remission, whether as standalone or in addition to a current treatment.

Patients stay engaged, results follow

Flow provides an engaging treatment experience that encourages patients to participate actively. This engagement results in excellent adherence: on average, 78% of patients follow the Flow treatment correctly (observation over the first six weeks).

User-friendliness for all

Designed for home use, Flow promotes patient autonomy while providing healthcare professionals with real-time data. This combination ensures efficient use and optimal integration into existing care pathways.

Integrating Flow into your treatment process

Flow fits easily into existing care plans to help provide new pathways to remission, whether as a standalone or augmented into existing care.

We provide structured documentation enabling progressive and secure implementation in your practice.

Our team offers continuous support, from initial introduction to clinical application. Newsletter subscription delivers regular scientific updates, usage recommendations, and Flow news.

Take the first steps in prescribing Flow

Step 1: Contact us and receive training

We provide comprehensive training so you can confidently prescribe Flow and explain it to your patients. You will get access to your portal and all key documents for easy device ordering.

Step 2: Prescribe Flow to your patients

You receive a resource package and an prescription and order form that allows you to request devices easily and conveniently. Alternatively, your patients can order directly through our webshop. We tailor the process flexibly to fit your practice workflow.

Step 3: Monitor progress and adjust treatment as needed

Track therapy progress through regular check-ins and customize treatment as necessary to achieve the best outcomes for your patients. We recommend a milestone review after 10 weeks to evaluate patient response and make adjustments if needed.

Flow Neuroscience Headset

Depression treated. Differently.

Company

Language:

Deutsch

Français

English

© Neurolite AG

Help – contact us!